Similarly, a T cell BsAb, combining the FRα specific binding moiety of MOv19 with a monovalent anti-human CD3 antibody, was shown to activate intratumoral T cells and induce tumor cell death; its efficacy was shown to be dependent on the presence of functional T cells in the microenvironment.64 The gene discussed is FOLR1; the disease is neoplasm.